Literature DB >> 8623946

Growth of microorganisms in propofol, thiopental, and a 1:1 mixture of propofol and thiopental.

J Crowther1, J Hrazdil, D T Jolly, J C Galbraith, M Greacen, M Grace.   

Abstract

To assess and compare the growth of four microorganisms in solutions of intravenous anesthetics, known quanta of Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Candida albicans were inoculated into propofol, thiopental, a 1:1 mixture of propofol and thiopental, and normal saline. All microorganisms were taken from standard stock cultures and incubated for 24 h (48 h for C. albicans). Growth of microorganism in each drug was compared by counting the number of colony forming units (CFUs) grown from a subculture of each inoculated anesthetic at 0, 3, 6, 12, and 24 h. The study shows that propofol strongly supports the growth of E. coli and C. albicans but is bacteriostatic toward S. aureus and weakly bactericidal toward P. aeruginosa. In contrast, both thiopental and the 1:1 mixture of propofol and thiopental behaved differently, exhibiting markedly bactericidal properties toward E. coli, S. aureus, and P. aeruginosa and a bacteriostatic effect on C. albicans. This finding supports recommendations that a strict aseptic technique should be used when handling propofol and that the contents of an ampoule should be used within 6 h of aspirating. The measured high pH of both thiopental and the 1:1 mixture of propofol and thiopental compared to propofol alone suggests pH to be a major factor in determining whether a given drug will support microbial growth.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8623946     DOI: 10.1097/00000539-199603000-00008

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  6 in total

Review 1.  The Role of GABA Receptor Agonists in Anesthesia and Sedation.

Authors:  Janette Brohan; Basavana G Goudra
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

2.  A novel, lipid-free nanodispersion formulation of propofol and its characterization.

Authors:  Hongming Chen; Zhong Zhang; Orn Almarsson; Jean-Francois Marier; Dina Berkovitz; Colin R Gardner
Journal:  Pharm Res       Date:  2005-03       Impact factor: 4.200

Review 3.  [Total intravenous anesthesia. On the way to standard practice in pediatrics].

Authors:  J M Strauss; J Giest
Journal:  Anaesthesist       Date:  2003-09       Impact factor: 1.041

4.  Comparison of propofol (1%) with admixture (1:1) of thiopentone (1.25%) and propofol (0.5%) for laryngeal mask airway insertion in children undergoing elective eye surgery: Double-masked randomized clinical trial.

Authors:  Renu Sinha; Dilip Shende; Rakesh Garg
Journal:  Indian J Anaesth       Date:  2010-03

5.  Investigating antimicrobial features and drug interactions of sedoanalgesics in intensive care unit: an experimental study.

Authors:  Ozge Unlu; Emre Sertac Bingul; Sevgi Kesici; Mehmet Demirci
Journal:  ADMET DMPK       Date:  2021-09-06

6.  Propofol lipidic infusion promotes resistance to antifungals by reducing drug input into the fungal cell.

Authors:  Sofia Costa-de-Oliveira; Ricardo Araujo; Ana Silva-Dias; Cidália Pina-Vaz; Acácio Gonçalves Rodrigues
Journal:  BMC Microbiol       Date:  2008-01-17       Impact factor: 3.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.